Transfer of monoclonal antibodies into breastmilk in neurologic and non-neurologic diseases
Open Access
- 1 July 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 7 (4)
Abstract
Objective To review currently available data on the transfer of monoclonal antibodies (mAbs) in the breastmilk of women receiving treatment for neurologic and non-neurologic diseases. Methods We systematically searched the medical literature for studies referring to 19 selected mAb therapies frequently used in neurologic conditions and “breastmilk,” “breast milk,” “breastfeeding,” or “lactation.” From an initial list of 288 unique references, 29 distinct full-text studies met the eligibility criteria. One additional study was added after the literature search based on expert knowledge of an additional article. These 30 studies were reviewed. These assessed the presence of our selected mAbs in human breastmilk in samples collected from a total of 155 individual women. Results Drug concentrations were typically low in breastmilk and tended to peak within 48 hours, although maximum levels could occur up to 14 days from infusion. Most studies did not evaluate the breastmilk to maternal serum drug concentration ratio, but in those evaluating this, the highest ratio was 1:20 for infliximab. Relative infant dose, a metric comparing the infant with maternal drug dose (Conclusions The current data are reassuring for low mAb drug transfer to breastmilk, but further studies are needed, including of longer-term effects on infant immunity and childhood development.Keywords
This publication has 55 references indexed in Scilit:
- Infliximab and Adalimumab Use During BreastfeedingJournal of Clinical Gastroenterology, 2012
- Breastfeeding and the Use of Human MilkPediatrics, 2012
- Perspectives on Immunoglobulins in Colostrum and MilkNutrients, 2011
- INTRAVITREAL BEVACIZUMAB DURING PREGNANCYRetina, 2010
- Adalimumab Level in Breast Milk of a Nursing MotherClinical Gastroenterology and Hepatology, 2010
- Treatment of Psoriasis with Anti-TNF Drugs during Pregnancy: Case Report and Review of the LiteratureDermatology, 2009
- Absence of Infliximab in Infants and Breast Milk From Nursing Mothers Receiving Therapy for Crohn's Disease Before and After DeliveryJournal of Clinical Gastroenterology, 2009
- Is infliximab safe to use while breastfeeding?World Journal of Gastroenterology, 2008
- Case Report: Evidence for Transplacental Transfer of Maternally Administered Infliximab to the NewbornClinical Gastroenterology and Hepatology, 2006
- Rate of Pregnancy-Related Relapse in Multiple SclerosisNew England Journal of Medicine, 1998